Abstract
The purpose of the study was to determine the prevalence in liver transplant (OLTx) patients of the hepatitis markers (anti-A, anti-B, anti-C, anti-D and HBsAg) and the interrelationships between markers and patients' sexes, ages, dates of transplant, clinicopathological diagnoses, and short-term survivals. Slightly more than half of the patients were male. Anti-A and anti-B were about evenly distributed between male and female. Anti-C, anti-D, and HBsAg were far more common in males. Age and year of transplant showed only a moderate increase in anti-A with increasing age. Anti-A was found in 57% of all patients, anti-B in 18%, anti-C in 17%, and HBsAg in 17%. Anti-D was tested only in patients who were positive for anti-B or HBsAg and occurred in 21 (11%) of 185. The poorest short-term survival occurred in males who showed both anti-A and HBsAg.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Demetris AJ, Jaffe R, Starzl TE: A review of adult and pediatric posttransplant liver pathology. Pathol Annu 22:347–386, 1987
MacSween RNM, Anthony PP, Schuer PJ (eds): Pathology of the Liver. New York, Churchill Livingstone, 1987
Szmuness W, Dienstag JL, Purcell RH, Stevens CE, Wong DC, Ikram H, Bar-Shany S, Beasly RP, Desmyter J, Gaon JA: The prevalence of antibody to hepatitis A antigen in various parts of the world: A pilot study. Am J Epidemiol 106:392, 1977
Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW: Association of primary sclerosing cholangitis with HLADRw52a. N Engl J Med 332:1842–1844, 1990
Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494–1500, 1989
Grendele M, Gridelli B, Colledan M, et al. Hepatitis C virus injection and liver transplantation. Lancet 1221, 1989
Centers for Disease Control: Protection against viral hepatitis. Delta hepatitis. MMWR 39(No. RR-2):22–23, 1990
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Blood Science Foundation, Pittsburgh, Pennsylvania 15213. Dr. El-Ashmawy held a Peace Fellowship from USAID.
Rights and permissions
About this article
Cite this article
Lewis, J.H., El-Ashmawy, L., Ramsey, G.E. et al. Hepatitis viral markers in patients undergoing primary liver transplants. Digest Dis Sci 38, 457–461 (1993). https://doi.org/10.1007/BF01316499
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316499